Carmen D. Zorrilla to Pregnancy
This is a "connection" page, showing publications Carmen D. Zorrilla has written about Pregnancy.
Connection Strength
1.198
-
Zorrilla CD, Rodr?guez-Figueroa L, Miranda-De Le?n S, L?pez-Alvarado B, P?rez E, Rabionet SE. Elimination of the Perinatal Transmission of HIV and Syphilis in Puerto Rico and Sustained Success since 2007: Convergence of Science, Women-Centered Care, and Policy. P R Health Sci J. 2021 03; 40(1):12-18.
Score: 0.132
-
Lebov JF, Arias JF, Balmaseda A, Britt W, Cordero JF, Galv?o LA, Garces AL, Hambidge KM, Harris E, Ko A, Krebs N, Marques ETA, Martinez AM, McClure E, Miranda-Filho DB, Moreira MEL, Mussi-Pinhata MM, Ochoa TJ, Osorio JE, Scalabrin DMF, Schultz-Cherry S, Seage GR, Stolka K, Ugarte-Gil CA, Vega CMV, Welton M, Ximenes R, Zorrilla C. International prospective observational cohort study of Zika in infants and pregnancy (ZIP study): study protocol. BMC Pregnancy Childbirth. 2019 Aug 07; 19(1):282.
Score: 0.118
-
Zorrilla CD, Rivera-Vi?as JI, De La Vega-Pujols A, Garcia-Garcia I, Rabionet SE, Mosquera AM. The Zika Virus Infection in Pregnancy: Review and Implications for Research and Care of Women and Infants in Affected Areas. P R Health Sci J. 2018 12; 37(Spec Issue):S66-S72.
Score: 0.113
-
Gely-Rojas L, Garc?a-Fragoso L, Negr?n J, Deynes D, Garc?a-Garc?a I, Zorrilla CD. Congenital Zika Syndrome in Puerto Rico, Beyond Microcephaly, A Multiorgan Approach. P R Health Sci J. 2018 12; 37(Spec Issue):S73-S76.
Score: 0.113
-
Zorrilla CD, Garc?a Garc?a I, Garc?a Fragoso L, De La Vega A. Zika Virus Infection in Pregnancy: Maternal, Fetal, and Neonatal Considerations. J Infect Dis. 2017 12 16; 216(suppl_10):S891-S896.
Score: 0.106
-
Zorrilla CD. The View from Puerto Rico - Hurricane Maria and Its Aftermath. N Engl J Med. 2017 Nov 09; 377(19):1801-1803.
Score: 0.104
-
Zorrilla CD, Van Dyke R, Bardeguez A, Acosta EP, Smith B, Hughes MD, Huang S, Watts DH, Heckman B, Jim?nez E, McSherry G, Mofenson L. Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants. Antimicrob Agents Chemother. 2007 Jun; 51(6):2208-10.
Score: 0.050
-
Zorrilla CD. HIV infection in women: perinatal issues and cervical cancer surveillance. Top HIV Med. 2007 Feb-Mar; 15(1):1-5.
Score: 0.050
-
Weinberg A, Muresan P, Richardson K, Fenton T, Dominguez T, Bloom A, Watts DH, Abzug MJ, Nachman SA, Levin MJ. Heterogeneity of T Cell Responses to Pandemic pH1N1 Monovalent Vaccine in HIV-Infected Pregnant Women. AIDS Res Hum Retroviruses. 2015 Nov; 31(11):1170-7.
Score: 0.045
-
Best BM, Burchett S, Li H, Stek A, Hu C, Wang J, Hawkins E, Byroads M, Watts DH, Smith E, Fletcher CV, Capparelli EV, Mirochnick M. Pharmacokinetics of tenofovir during pregnancy and postpartum. HIV Med. 2015 Sep; 16(8):502-11.
Score: 0.044
-
Williams PL, Karalius B, Patel K, Aschengrau A, Chakhtoura N, Enriquez N, Moye J, Garvie PA, Monte D, Seage GR, Zorrilla C, Mussi-Pinhata MM. Fetal growth assessed via ultrasound in relation to maternal HIV infection status and antiretroviral regimens. AIDS. 2024 03 15; 38(4):567-577.
Score: 0.040
-
Silva-Suarez G, Rabionet SE, Zorrilla CD, Perez-Menendez H, Rivera-Leon S. Pregnant Women's Experiences during Hurricane Maria: Impact, Personal Meaning, and Health Care Needs. Int J Environ Res Public Health. 2021 08 12; 18(16).
Score: 0.034
-
Valdes V, Zorrilla CD, Gabard-Durnam L, Muler-Mendez N, Rahman ZI, Rivera D, Nelson CA. Cognitive Development of Infants Exposed to the Zika Virus in Puerto Rico. JAMA Netw Open. 2019 10 02; 2(10):e1914061.
Score: 0.030
-
Rabionet SE, Zorrilla CD, Rivera-Vi?as JI, Guerra-Sanchez Y. Pregnancy and Zika: The Quest for Quality Care and Reproductive Justice. P R Health Sci J. 2018 12; 37(Spec Issue):S45-S50.
Score: 0.028
-
Ramgopal M, Osiyemi O, Zorrilla C, Crauwels HM, Ryan R, Brown K, Hillewaert V, Baugh B. Pharmacokinetics of Total and Unbound Etravirine in HIV-1-Infected Pregnant Women. J Acquir Immune Defic Syndr. 2016 11 01; 73(3):268-274.
Score: 0.024
-
Eley T, Huang SP, Conradie F, Zorrilla CD, Josipovic D, Botes M, Osiyemi O, Hardy H, Bertz R, McGrath D. Clinical and pharmacogenetic factors affecting neonatal bilirubinemia following atazanavir treatment of mothers during pregnancy. AIDS Res Hum Retroviruses. 2013 Oct; 29(10):1287-92.
Score: 0.019
-
L?pez-Cepero R, Lynch L, Zorrilla C, Leavitt K, de la Vega A. Antenatal screening for Down syndrome with special considerations in the Puerto Rican population. P R Health Sci J. 2011 Dec; 30(4):206-10.
Score: 0.017
-
Chen KT, Tuomala RE, Chu C, Huang ML, Watts DH, Zorrilla CD, Paul M, Hershow R, Larussa P. No association between antepartum serologic and genital tract evidence of herpes simplex virus-2 coinfection and perinatal HIV-1 transmission. Am J Obstet Gynecol. 2008 Apr; 198(4):399.e1-5.
Score: 0.013
-
Minkoff H, Shen X, Xian LS, Watts DH, Leighty R, Hershow R, Palefsky J, Tuomala R, Neu N, Zorrilla CD, Paul M, Strickler H. Relationship of pregnancy to human papillomavirus among human immunodeficiency virus-infected women. Obstet Gynecol. 2006 Oct; 108(4):953-60.
Score: 0.012
-
Navas-Nacher EL, Read JS, Leighty RM, Tuomala RE, Zorrilla CD, Landesman S, Rosenblatt H, Hershow RC. Mode of delivery and postpartum HIV-1 disease progression: the Women and Infants Transmission Study. AIDS. 2006 Feb 14; 20(3):429-36.
Score: 0.012
-
Morris AB, Dobles AR, Cu-Uvin S, Zorrilla C, Anderson J, Harwell JI, Keller J, Garb J. Protease inhibitor use in 233 pregnancies. J Acquir Immune Defic Syndr. 2005 Sep 01; 40(1):30-3.
Score: 0.011
-
Tuomala RE, Watts DH, Li D, Vajaranant M, Pitt J, Hammill H, Landesman S, Zorrilla C, Thompson B. Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy. J Acquir Immune Defic Syndr. 2005 Apr 01; 38(4):449-73.
Score: 0.011
-
Magder LS, Mofenson L, Paul ME, Zorrilla CD, Blattner WA, Tuomala RE, LaRussa P, Landesman S, Rich KC. Risk factors for in utero and intrapartum transmission of HIV. J Acquir Immune Defic Syndr. 2005 Jan 01; 38(1):87-95.
Score: 0.011
-
Thorpe LE, Frederick M, Pitt J, Cheng I, Watts DH, Buschur S, Green K, Zorrilla C, Landesman SH, Hershow RC. Effect of hard-drug use on CD4 cell percentage, HIV RNA level, and progression to AIDS-defining class C events among HIV-infected women. J Acquir Immune Defic Syndr. 2004 Nov 01; 37(3):1423-30.
Score: 0.011
-
Charurat M, Blattner W, Hershow R, Buck A, Zorrilla CD, Watts DH, Paul M, Landesman S, Adeniyi-Jones S, Tuomala R. Changing trends in clinical AIDS presentations and survival among HIV-1-infected women. J Womens Health (Larchmt). 2004 Jul-Aug; 13(6):719-30.
Score: 0.010
-
Acosta EP, Bardeguez A, Zorrilla CD, Van Dyke R, Hughes MD, Huang S, Pompeo L, Stek AM, Pitt J, Watts DH, Smith E, Jim?nez E, Mofenson L. Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women. Antimicrob Agents Chemother. 2004 Feb; 48(2):430-6.
Score: 0.010
-
Minkoff H, Hershow R, Watts DH, Frederick M, Cheng I, Tuomala R, Pitt J, Zorrilla CD, Hammill H, Adeniyi-Jones SK, Thompson B. The relationship of pregnancy to human immunodeficiency virus disease progression. Am J Obstet Gynecol. 2003 Aug; 189(2):552-9.
Score: 0.010
-
Bardeguez AD, Shapiro DE, Mofenson LM, Coombs R, Frenkel LM, Fowler MG, Huang S, Sperling RS, Cunningham B, Gandia J, Maupin R, Zorrilla CD, Jones T, O'Sullivan MJ. Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival. J Acquir Immune Defic Syndr. 2003 Feb 01; 32(2):170-81.
Score: 0.009
-
Tuomala RE, O'Driscoll PT, Bremer JW, Jennings C, Xu C, Read JS, Matzen E, Landay A, Zorrilla C, Blattner W, Charurat M, Anderson DJ. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis. 2003 Feb 01; 187(3):375-84.
Score: 0.009